A Phase 1, Open-Label, 2-Period, Fixed Sequence Study to Investigate the Absorption, Distribution, Metabolism and Excretion of [14C]PF-07081532 and to Assess the Absolute Bioavailability and Fraction Absorbed of PF-07081532 in Healthy Male Participants Us

A Study to Find Out What Happens to Lotiglipron in the Body of Healthy Men

A Phase 1, Open-Label, 2-Period, Fixed Sequence Study to Investigate the Absorption, Distribution, Metabolism and Excretion of [14C]PF-07081532 and to Assess the Absolute Bioavailability and Fraction Absorbed of PF-07081532 in Healthy Male Participants using a 14C Microtracer Approach

Category & Conditions: Diabetes and Metabolic Disorders

Medicine: PF-07081532

ClinicalTrials.gov Identifier (NCT): NCT05652647

Protocol ID: C3991006

Print Download

Open Plain Language Summary Result: Click here